| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 10 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-13 |
4 |
AS |
$135.25 |
$2,143,036 |
D/D |
(15,845) |
1,043,662 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-17 |
4 |
AS |
$140.14 |
$4,582,866 |
D/D |
(32,689) |
1,043,662 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-13 |
4 |
OE |
$17.65 |
$433,166 |
D/D |
24,542 |
1,051,728 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-16 |
4 |
OE |
$17.65 |
$565,630 |
D/D |
32,047 |
1,053,321 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-13 |
4 |
OE |
$6.90 |
$109,331 |
D/D |
15,845 |
1,059,507 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-14 |
4 |
OE |
$17.65 |
$617,750 |
D/D |
35,000 |
1,062,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-15 |
4 |
OE |
$17.65 |
$617,750 |
D/D |
35,000 |
1,062,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-12-19 |
4 |
OE |
$5.18 |
$181,300 |
D/D |
35,000 |
1,066,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-17 |
4 |
OE |
$6.90 |
$225,554 |
D/D |
32,689 |
1,076,351 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-21 |
4 |
OE |
$6.90 |
$908,065 |
D/D |
110,930 |
1,088,656 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-08-15 |
4 |
AS |
$106.36 |
$9,110,847 |
D/D |
(85,452) |
1,091,217 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-04-29 |
4 |
OE |
$10.29 |
$681,301 |
D/D |
66,210 |
1,098,541 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-05-20 |
4 |
OE |
$10.29 |
$736,144 |
D/D |
70,000 |
1,102,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-05-27 |
4 |
OE |
$11.92 |
$834,400 |
D/D |
70,000 |
1,102,331 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-04 |
4 |
OE |
$17.98 |
$1,540,311 |
D/D |
85,668 |
1,106,942 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-12 |
4 |
OE |
$17.65 |
$1,420,084 |
D/D |
80,458 |
1,107,644 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-05 |
4 |
OE |
$17.98 |
$1,634,724 |
D/D |
90,919 |
1,112,193 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-06-20 |
4 |
OE |
$11.92 |
$1,076,138 |
D/D |
90,280 |
1,122,611 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-12-18 |
4 |
OE |
$5.10 |
$818,570 |
D/D |
145,664 |
1,171,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-08-05 |
4 |
S |
$116.87 |
$341,144 |
D/D |
(2,919) |
1,176,669 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-07-30 |
4 |
AS |
$109.56 |
$24,384,037 |
D/D |
(212,737) |
1,179,588 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-05-14 |
4 |
AS |
$105.38 |
$3,289,759 |
D/D |
(31,113) |
1,361,212 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-05-13 |
4 |
AS |
$104.94 |
$652,727 |
D/D |
(6,220) |
1,392,325 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-05-10 |
4 |
AS |
$100.12 |
$3,504,200 |
D/D |
(35,000) |
1,398,545 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-04-17 |
4 |
AS |
$95.04 |
$3,326,400 |
D/D |
(35,000) |
1,433,545 |
0 |
- |
|
283 Records found
|
|
Page 10 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
